Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms.

ABSTRACT:

SUBMITTER: Tong J 

PROVIDER: S-EPMC7613297 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature